ideasIdea

Ultrasound-assisted blood test instead of a brain biopsy

Brain tumours shed very little DNA into blood, so a sonobiopsy briefly opens the brain's barrier with focused ultrasound to release enough to read from a blood sample.

Focused ultrasound with microbubbles transiently opens the blood-brain barrier, and first-in-human sonobiopsy studies report severalfold increases in circulating tumour DNA and brain-derived proteins after sonication, without lasting damage. This could replace repeat surgical biopsy for molecular diagnosis, resistance monitoring and response assessment in glioma and brain metastases.

Hypothesis

Focused ultrasound sonication before blood sampling raises the detection rate of tumour-specific mutations in plasma from under 20% to over 70% in glioma, with no grade 3 adverse events.

Rationale

The barrier is the reason brain tumour liquid biopsy fails, and opening it is now a routine procedure in movement disorder and Alzheimer's trials. Diagnostic use requires only transient opening, which is a lower safety bar than drug delivery.

What would test it

A prospective study in patients undergoing planned resection: sonobiopsy plasma versus tissue as reference standard, reporting sensitivity, specificity and safety.

Maturity

early clinical

Who has to act

engineering

Cost to try

Medium ($1M to $50M)

Years to first evidence

Bottlenecks it attacks

The brain: barrier and sanctuary · Most drugs cannot cross into the brain, so brain tumours and brain metastases lag every other site.
Tumour heterogeneity and clonal evolution · A tumour is many tumours. Treatments that kill most cells leave the rest to grow back, changed.

Connected

9top

Pages like this

not linked directly; found by shared links

Ultrasound-assisted blood test instead of a brain biopsy

Connected

Pages like this

cancers

technologies

companies

terms

bottlenecks